Atossa Genetics Inc. (NASDAQ:ATOS) has reported that the US Food and Drug Administration, the federal regulatory body, has sought more information and data to further review an application for a breast aspirator called ForeCYTE, developed by ATOS. Atossa Genetics Inc (NASDAQ:ATOS) stock opened at $1.85 in last session, and closed at $1.88, while the day range of ATOS stock is $1.75-$1.90. The stock showed a negative weekly performance of -20.00%.
Bioline, The PCR Company, a wholly-owned subsidiary of Meridian Bioscience, Inc. (NASDAQ:VIVO), is proud to announce the worldwide release of the SensiFAST(TM) cDNA synthesis kit. Powered by a newly developed Reverse Transcriptase enzyme with enhanced properties and in combination with the unique TransAmp(TM) buffer; SensiFAST(TM) cDNA synthesis kit is the choice for scientists who need consistent, unbiased, first-strand cDNA synthesis necessary for high sensitivity real-time PCR experiments. Meridian Bioscience, Inc. (NASDAQ:VIVO) stock opened at $20.85, in last session and closed at $20.43, by loosed -1.02%.The 52 week range was $19.15-$27.72.Company’s market capitalization is $848.89 million.
IDEXX Laboratories (NASDAQ:IDXX) Director Thomas Craig unloaded 4,800 shares of the company’s stock on the open market in a transaction dated Wednesday, February 19th. The shares were sold at an average price of $125.42, for a total transaction of $602,016.00. Following the completion of the transaction, the director now directly owns 11,976 shares of the company’s stock, valued at approximately $1,502,030. The transaction was disclosed in a document filed with the Securities & Exchange Commission. IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock gained 1.21% and finished the last session at $126.09.The EPS of the stock remained 3.52.Company’s market capitalization is $6.51 billion.
Vermillion, Inc. (NASDAQ: VRML), a multivariate diagnostics company focused on gynecologic cancers and women’s health, has been invited to present at ROTH Capital Partners 26th Annual Conference being held March 10-12, 2014, at the Ritz-Carlton in Dana Point, California. Vermillion, Inc. (NASDAQ:VRML) stock opened the session at $3.26, and closed the session at $3.34. The 52 week range of the VRML stock remained $1.03-$4.07 and the day range was $3.26-$3.83.